Exelon Corp director David G. DeWalt received an annual award of 3,720 restricted stock units (RSUs) designated as 2026 Directors Restricted Stock Units. These RSUs were granted as compensation under the Exelon Long-term Incentive Plan.
The award will fully vest on April 28, 2027 and then be settled in Exelon common stock on a 1-for-1 basis, meaning each unit converts into one share. The RSUs will also accrue additional stock units through dividend reinvestment, which will vest at the same time as the original award. Following this grant, DeWalt holds 3,720 of these RSUs directly.
Cheshire Marjorie Rodgers reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Marjorie Rodgers reported routine equity-based compensation and existing deferred balances. On 2026-04-28, she received a grant of 3,720 "2026 Directors Restricted Stock Units" under the Exelon Long-term Incentive Plan. These RSUs will fully vest and be settled in Exelon common stock on a 1-for-1 basis on 2027-04-28, and will also accrue additional stock units through dividend reinvestment that vest with the underlying award.
Rodgers also reported 10,013 deferred phantom share equivalents tied to Exelon common stock in a non-qualified deferred compensation plan. These phantom share equivalents are settled in cash on a 1-for-1 basis when her service on the board ends. No open-market purchases or sales were reported in this filing.
BOWERS WILLIAM P reported acquisition or exercise transactions in this Form 4 filing.
EXELON CORP director William P. Bowers received a compensation-related equity award and reported existing deferred units. On 2026-04-28, he was granted 3,720 "2026 Directors Restricted Stock Units" under the Exelon Long-term Incentive Plan. These RSUs will vest and be settled in Exelon common stock on a 1-for-1 basis and will accrue additional stock units through dividend reinvestment.
He also reported 20,158 deferred phantom share equivalents tied to Exelon common stock in a non-qualified deferred compensation plan. According to the plan, these phantom share equivalents will be settled in cash on a 1-for-1 basis when his service on the board ends.
Vanguard Portfolio Management reports beneficial ownership of 54,847,064 shares of Exelon Corp common stock as of 03/31/2026. This position represents 5.36% of the class and reflects sole dispositive power over the shares, with 181,630 shares of sole voting power.
Exelon Corporation reports that subsidiary PECO Energy has withdrawn its previously filed 2026 electric and natural gas distribution rate review proceedings with the Pennsylvania Public Utility Commission. PECO cites significant financial pressures on households and businesses and a desire to prioritize customer affordability while maintaining safe, reliable service.
Separately, the Maryland Utility RELIEF Act has passed the Maryland General Assembly and, if signed, will modify the regulatory framework for cost recovery for Exelon subsidiaries BGE, Pepco, and DPL in Maryland. In response to these developments, Exelon plans to redeploy and delay certain capital projects and pursue operational efficiencies.
Exelon reaffirms its 2026 Adjusted (non-GAAP) operating earnings guidance of $2.81–$2.91 per share and its expectation that cumulative annualized Adjusted (non-GAAP) operating earnings growth from 2025 to 2029 will be near the top end of the 5–7% range.
Exelon Corp director Bryan K. Segedi received an award of 878 common stock deferred stock units at $49.82 per unit under the Exelon Corp. Directors Deferred Stock Unit Plan. Following this grant, he holds 9,451 deferred stock units indirectly, including 72 units acquired through automatic dividend reinvestment.
Rogers Matthew C reported acquisition or exercise transactions in this Form 4 filing.
EXELON CORP director Matthew C. Rogers reported compensation-related equity awards. He received 739 deferred phantom share equivalents tied to Exelon common stock at $49.02 per equivalent, bringing his balance in this derivative instrument to 739 units, with 98 of these obtained through automatic dividend reinvestment.
He was also granted 878 shares of common stock in the form of deferred stock units at $49.82 per unit, held indirectly through the Exelon Corp. Directors Deferred Stock Unit Plan, increasing that plan balance to 12,554 units. The phantom share equivalents are part of a non-qualified deferred compensation plan and will be settled in cash on a 1-for-1 basis after his service on the board ends.
Exelon Corp director Anna Richo reported a grant of 878 common stock deferred stock units valued at $49.82 per unit. These units were credited under the Exelon Corp. Directors Deferred Stock Unit Plan and are held as an indirect interest, bringing her deferred stock unit balance to 11,337 units, including 87 acquired through automatic dividend reinvestment.
Separately, she holds 7,930 deferred phantom share equivalents in an Exelon stock fund within a multi-fund, non-qualified deferred compensation plan. According to the disclosure, these phantom share equivalents, which include 66 accrued through automatic dividend reinvestment, will be settled for cash on a 1-for-1 basis with Exelon common stock when her service on the board ends.
Lillie Charisse R reported acquisition or exercise transactions in this Form 4 filing.
Exelon Corp director Charisse R. Lillie reported routine equity-based compensation awards. She received 5 deferred phantom share equivalents tied to Exelon common stock at $49.02 per equivalent, bringing her phantom share balance to 3,855 equivalents. She was also credited with 878 common stock deferred stock units at $49.82 per unit through the Exelon Corp Directors Deferred Stock Unit Plan, increasing that plan balance to 12,554 units. Separately, she holds 7,246 shares of common stock directly, with both the share and phantom equivalent balances including amounts added through automatic dividend reinvestment. The phantom share equivalents are part of a non-qualified deferred compensation plan and will be settled for cash on a one-for-one basis when her board service ends.
Exelon Corp director Linda P. Jojo received a grant of 878 common stock deferred stock units on March 31, 2026, credited under the Exelon Corp Directors Deferred Stock Unit Plan. The units were valued at $49.82 per share. After this award, her indirect holdings total 56,036 deferred stock units, including 461 additional units acquired through automatic dividend reinvestment.